Investor
General Atlantic, Centene and AXA Venture Partners led the Series D round.
This latest infusion of cash values Collective Health at $1.5 billion.
Coming in six months after its $26 million Series A round, Headway now boasts $103 million in total funding and a new valuation of $750 million.
Alife also added Deena Shakir, a partner at Lux Capital, to its board of directors.
PeriGen will continue its focus on a perinatal clinical decision support tool.
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.
The fund plans to target disruptors in the digital health space that focus on making healthcare more accessible, affordable and simple.
Teladoc reports a net loss of $1.31 per share, a total of $199.6 million.
The AI training provider is the first Lithuanian startup to be selected for the programme and one of several Lithuanian startups to gain funding recently.
Also: UCM Digital Health closes Series A for company growth, MD Ally raises $3.5M in seed round and Votive Health launches with $2.5M.